Gyeonggi, South Korea

Koo Hun Chung

This inventor holds 2 USPTO granted patents. Top assignee: Chong Kun Dang Corporation. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Koo Hun Chung. Retrieved from https://idiyas.com/inventor/koo-hun-chung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Koo Hun Chung: Innovator in Nucleoside Derivatives

Introduction

Koo Hun Chung is a notable inventor based in Kyeonggi-do, South Korea. He has made significant contributions to the field of chemistry, particularly in the development of nucleoside derivatives. With a total of 2 patents to his name, Chung's work has implications for various applications in pharmaceuticals and biotechnology.

Latest Patents

Chung's latest patents include innovative processes for preparing nucleoside derivatives. These patents are titled "Nucleoside derivatives and process for preparing the same" and "Nucleoside derivatives and process for preparing thereof." These inventions showcase his expertise and commitment to advancing scientific knowledge in his field.

Career Highlights

Koo Hun Chung is currently employed at Chong Kun Dang Corporation, a prominent pharmaceutical company in South Korea. His role at the company allows him to apply his innovative ideas and contribute to the development of new therapeutic solutions.

Collaborations

Chung has collaborated with talented coworkers, including Jung Woo Kim and Soon Kil Ahn. These partnerships have likely enhanced his research and development efforts, leading to successful innovations in nucleoside chemistry.

Conclusion

Koo Hun Chung is a distinguished inventor whose work in nucleoside derivatives has the potential to impact the pharmaceutical industry significantly. His contributions, along with his collaborations, highlight the importance of innovation in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…